Insights On Upstream Manufacturing

  1. CellShot PFEP™ + Proliva™: Enhancing Post-EP Proliferation 9/2/2025

    Electroporation-induced stress limits the success of non-viral gene editing. Learn about an approach that mitigates thermal and electrical damage to significantly boost cell proliferation and preserve organelle integrity

  2. Navigating Challenging Cell Engineering Workflows With A Scalable, Proven Electroporation Platform 9/1/2025

    Discover how a scalable, non-viral electroporation platform delivers complex payloads into hard-to-transfect cells, ensuring high efficiency and viability from discovery to clinical-scale production.

  3. Challenges In Scaling Allogeneic Processes 9/1/2025

    Learn practical strategies for optimizing harvest, cell separation, and large-volume freezing to ensure process efficiency, reduce risk, and maintain product viability.

  4. CellThera™ Leads The Way: Innovation In Gamma Delta T Cell Media 9/1/2025

    Learn about a targeted cell culture strategy that addresses unique metabolic needs, enabling over 20,000-fold expansion of gamma-delta T cells—a critical step for scalable manufacturing.

  5. From Black Box To Precision: A New Era Of Glycan Control 8/27/2025

    Glycoprotein therapies face variable glycan profiles. An alternative approach, IVGE, moves modification outside the cell for true molecular control, ensuring consistency and speed.

  6. Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields 8/27/2025

    Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.

  7. Streamlining Cell Line Development For Antibodies 8/27/2025

    Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

  8. N-1 Perfusion Strategies For Commercial-Ready Biologics 8/27/2025

    Learn how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.

  9. Elevating mRNA Manufacturing Toward GMP-Readiness 8/27/2025

    The mRNA Technology Transfer Program empowers LMICs with scalable vaccine production. Learn about a partnership that drives innovation in mRNA and sets a global blueprint for equitable health access.

  10. Unlock Viral Vector Yield And Efficiency With Upstream Intensification 8/26/2025

    Streamline viral vector manufacturing with perfusion technologies that reduce costs and improve scalability. Discover how a tangential flow depth filtration system enhances yield and quality.